We will discuss regulatory oversight of clinical trials that use decentralized components. Through this presentation, the audience will hear about regulatory requirements and expectations of the coordination of these trials while using the unique aspects of ‘hybrid’ components.

CEU: 1.00 ACRP

Speaker:

Eric Pittman, MBA, Director, Bioresearch Monitoring Division (West), U.S. Food and Drug Administration